Morimatsu Pharmaceutical Equipment key facts
as of Oct 2026- Provider of core equipment, process systems and digitalized total factory solutions for pharmaceutical, biopharmaceutical, FMCG, cosmetic and e-chemical industries.
- Morimatsu Pharmaceutical Equipment is valued at approximately $352.4M as of Oct 2026 (last reported valuation).
- It has raised $46.0M; the latest was Later Stage VC ($46.0M) in Jul 2025.
- Notable investors include Suzhou Asset Management, CICC Private Equity.
- Status: Privately Held (backing).
Morimatsu Pharmaceutical Equipment's last reported valuation, Jul 2025. Nothing priced has surfaced since.
- ·Watch Morimatsu Pharmaceutical Equipment: the Monday email on marks, rounds and moves
Morimatsu Pharmaceutical Equipment funding rounds
No funding rounds for Morimatsu Pharmaceutical Equipment are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Morimatsu Pharmaceutical Equipment
2Morimatsu Pharmaceutical Equipment valuation
Morimatsu Pharmaceutical Equipment's last reported valuation was $352 million in Jul 2025. No priced round, secondary trade or fund mark has surfaced since.
Morimatsu Pharmaceutical Equipment investors
2 investors are on record for Morimatsu Pharmaceutical Equipment, including Suzhou Asset Management and CICC Private Equity.
About Morimatsu Pharmaceutical Equipment
Provider of core equipment, process systems and digitalized total factory solutions for pharmaceutical, biopharmaceutical, FMCG, cosmetic and e-chemical industries. The company's products include bioreactors, fermenter systems, tangential flow filtration systems, in-line dispensing systems, wet granulators, multi-functional fluidized beds, WD multi-functional filtration and washing dryers (three-in-one), sanitary containers, and heat exchangers.
- Sector
- Business Products and Services (B2B)
- HQ
- Shanghai, China
- Founded
- 2001
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.